Table 1.
Research model | Background/source | Inflammation (ALP/ALT/AST) | Ductular reaction | Liver fibrosis | References |
---|---|---|---|---|---|
BDL | Various | Yes | Yes | Yes | [15, 16] |
DDC | Various | Yes | Yes | Yes | [18] |
TAA | Various | Yes | Yes | Yes | [23] |
CCl4 | Various | Yes | Yes | Yes | [24, 25, 26] |
Mdr2−/− mice | FVB/NJ mice | Yes | Yes | Yes | [28, 29] |
Cftr−/− mice | C57BL/6J mice | Yes | Yes | Yes | [35, 36] |
CDH1ΔL mice | C57BL/6J mice | Yes | Unknown | Yes | [38] |
Vil2kd/kd mice | Unknown | Yes | Yes | Yes | [48] |
Primary PSC cholangiocytes | Humans | N/A | N/A | N/A | [51, 52] |
ALP = alkaline phosphatase; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BDL=bile duct ligation; CCl4 = carbon tetrachloride; DDC=3,5-deithoxycarbonyl-1,4-dihydrocollidine; TAA=thioacetamide; PSC = primary sclerosing cholangitis.